High materiality9/10
Pyxis Oncology Inc. (PYXS) PT Raised to $8 at Wedbush
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
PYXS received an analyst target update from Wedbush. Target: $8; Posted price: $3.38; Analyst: Robert Driscoll.
- Target $8; Price $3.38; Wedbush; Analyst Robert Driscoll
Key facts
- 01
Target: $8
- 02
Posted price: $3.38
- 03
Analyst firm: Wedbush
- 04
Analyst: Robert Driscoll
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.